FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HU, V. W.
Right arrow Articles by HEIKKA, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HU, V. W.
Right arrow Articles by HEIKKA, D. S.
(The FASEB Journal. 2000;14:448-454.)
© 2000 FASEB

Radiolabeling revisited: metabolic labeling with 35S-methionine inhibits cell cycle progression, proliferation, and survival

VALERIE W. HU1 and DANIEL S. HEIKKA

Department of Biochemistry and Molecular Biology, The George Washington University, School of Medicine and Health Sciences, Washington, D.C. 20037, USA

1Correspondence: Department of Biochemistry and Molecular Biology, The George Washington University, School of Medicine and Health Sciences, Ross Hall, Room 526, 2300 Eye St., N.W., Washington, DC 20037, USA. E-mail: bcmvwh{at}gwumc.edu


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
APPENDIX 1
APPENDIX 2
REFERENCES
 
Metabolic labeling of cells with low-energy beta-emitting radioisotopes such as [35S]methionine is often used to follow the biosynthesis, maturation, and degradation of proteins in vivo. Such techniques have generally been assumed to be relatively nonperturbing to the cell. The results presented here indicate that metabolic labeling of cells with [35S]methionine under standard experimental conditions can inhibit cell progression into mitosis, cause cell cycle arrest, inhibit cell proliferation in both short-term and colony-forming assays, alter cell morphology, and induce apoptosis over the course of several days. These results thus suggest the need for caution in interpretation of studies using such methods, especially if the experiments rely on the normal progression of the cell cycle or are intended to monitor events occurring in a normally proliferating cell.—Hu, V. W., Heikka, D. S. Radiolabeling revisited: metabolic labeling with 35S-methionine inhibits cell cycle progression, proliferation, and survival.


Key Words: metabolic radiolabeling • beta emitters • cell cycle arrest • apoptosis


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
APPENDIX 1
APPENDIX 2
REFERENCES
 
DESPITE GENERAL ACCEPTANCE of metabolic radiolabeling as an innocuous treatment, several reports have demonstrated that radioisotopes can induce DNA fragmentation (1) and elevation of p53 (2 , 3) , a tumor suppressor protein that is a key cell cycle checkpoint regulator that monitors DNA damage. One group associated the radioisotope-induced elevation of p53 with sustained growth arrest or apoptosis, depending on the cell type (3) . Such harmful effects of radiolabels may not be apparent in the absence of deliberate attempts to induce cells to divide in a synchronous manner, which may explain why there is relatively little documentation of this phenomenon. On the other hand, the radiotoxicity of low-energy beta emitters has been long appreciated by radiobiologists (4 5 6) , although not investigated at the molecular level or within the context of cell cycle progression.

Although the implications of radiation damage induced by radioisotopes during metabolic labeling have not been widely considered, many studies have focused on the molecular and cellular effects of {gamma}- and UV radiation (7 8 9 10 11) . For example, UV irradiation of cells has been shown to cause G1 as well as G2 checkpoint arrest involving p53-dependent induction of p21Cip1/Waf1 or phosphorylation of inhibitory residues of cdc2, respectively (7 , 8) . {gamma}-Irradiation has also been shown to induce p53-dependent cell cycle arrest that can be manifested over multiple cell cycles (11) . In addition, {gamma}-irradiation has been associated with reduced long-term survival or clonogenicity of cells in culture (11) . In both cases, the primary target of radiation damage is DNA, thus activating the DNA damage molecular sensors at both the G1 (p53) and G2 (cdc2) checkpoints. With respect to low-energy ß-emitting radioisotopes, the targets as well as mechanism(s) of radiation damage are neither well understood nor well investigated. We report here that [35S]methionine at normal doses used in metabolic labeling studies substantially interferes with cell cycle progression and survival.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
APPENDIX 1
APPENDIX 2
REFERENCES
 
Chemicals
Nocodazole, thymidine, L-mimosine, L-methionine, and propidium iodide were obtained from Sigma (St. Louis, Mo.). Annexin V-Oregon Green was obtained from Trevigen, Inc. (Gaithersburg, Md.). All media and buffers were purchased from Fisher (Pittsburgh, Pa.). 35S-Trans label was purchased from ICN (Irvine, Calif.) and both [35S]methionine in Redivue buffer and [35S]methionine in vivo cell label were purchased from Amersham (Arlington Heights, Ill.). ICN and Amersham kindly made available to us the corresponding carrier buffers in which the labels were dissolved for use in our unlabeled controls.

Cells and culture media
Two different lines of rabbit smooth muscle cells (A6 and B1) were kindly provided by Dr. Gene Liau (Novartis Pharmaceuticals). The A6 line is a cell line transfected with the gene for human acidic fibroblast growth factor (FGF-121–154) in plasmid p267–3. The B1 line was transfected with the plasmid alone. Both of these cell lines were cultured in M199 medium supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, Ga.), 2 mM glutamine, antibiotic/antimycotic solution to final concentrations of 100 U/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B, and geneticin at 250 µg/ml. The NIH 3T3 murine fibroblasts were obtained from Dr. Patricia Berg (GWUMC) and were cultured in Dulbecco’s minimum essential medium (DMEM) supplemented with 10% FBS. The human prostate carcinoma cell line, DU145, was obtained from Dr. Mahnaz Badamchian (GWUMC) and cultured in DMEM:F12 (1:1) medium supplemented with 10% FBS. Other than the experiments described in Fig. 2 , the A6 rabbit smooth muscle line was used for all experiments described in this report.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 2. Effect of [35S]methionine on mitotic induction in different cell types. Cells were incubated with radiolabel and nocodazole as described in Materials and Methods. The numbers of mitotic cells were determined for both radiolabeled (filled bars) and control (open bars) cells. The results show the mean number of mitotic cells (± SE) in 5 areas/dish on duplicate sets of dishes containing A) rabbit smooth muscle cells, A6; B) rabbit smooth muscle cells, B1; C) NIH 3T3 mouse fibroblasts; D) human prostate carcinoma cells, DU145. *P<0.01 vs. control.

Mitotic arrest and cell synchronization protocols
Unsynchronized cells were incubated with the radiolabel at 100 µCi/ml for 2 h in prewarmed Met-deficient DMEM supplemented with 10% dialyzed FBS, 2 mM L-Gln, antibiotic/antimycotic, and 1 mg/l cold Met before addition of nocodazole (Sigma) at 0.04 µg/ml and overnight incubation to accumulate mitotic cells (~15 h). The control cells were treated with equivalent volumes of the respective carrier buffers instead of the label. The number of mitotic cells (those that were visibly rounded on the culture dish) were counted within several 20x fields on an Olympus CK inverted phase contrast microscope.

Cells were synchronized to the G1/S interface by a thymidine/mimosine double block procedure (12) . This involved an intial 12 h treatment with 2 mM thymidine, followed by a wash and further culture in complete M199 medium (10–12 h). A second block was induced with mimosine (400 µM) for 12–14 h, at which time the cells were arrested in G1 as confirmed by PI staining and scanning laser cytometry (see Fig. 3A ).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Fluorescence profiles of PI-stained cells after synchronization and release from mimosine block. PI fluorescence was quantitated by scanning laser cytometry as described previously (13) . A) Unlabeled synchronized cells immediately after mimosine washout. B) Unlabeled synchronized cells 8 h after mimosine washout. C) Unlabeled cells 24 h after mimosine washout. D) [35S]methionine-labeled cells 24 h after mimosine washout. An average of 1956 cells were analyzed per sample.

Cell cycle analysis of anchored cells
Cell cycle analyses were performed on propidium iodide (PI) -stained anchored cells as described previously (13) . To quantitate cell-associated PI fluorescence, cells were fixed at 2 h intervals after release from the mimosine block with 50% cold methanol/phosphate-buffered saline (PBS) for 0.5 h at 4°C and then stained with PI (0.05 mg/ml in 0.1% sodium citrate, pH 7) for 4 min at 4°C. The PI staining was done either with or without prior RNase treatment (1 mg/ml for 30 min at 37°C) of the fixed cells with the same results. Fluorescence analyses were performed using a Meridian ACAS 570 Interactive Laser Cytometer and the Image Analysis program, with excitation of the fluor at 488 nm. The program automatically collects and processes fluorescence values over a programmable region of the culture dish. Basically, 5–10 areas (720 µ x 720 µ) were analyzed per sample for cell-associated fluorescence. Histograms depicting the fluorescence profile of a minimum of 1956 cells were prepared using the Meridian Instrument’s ‘Histogram’ program, which combines data from the different fields examined. Figure 3 depicts the relative number of cells as a function of integrated fluorescence.

Proliferation assays
In a short-term assay, cells were labeled for 2 h with 35S-Trans label at 100 µCi/ml, washed, and then left in culture for the indicated number of days before counting viable cells with a hemacytometer. Trypan blue staining immediately after labeling did not reveal any significant decrease in cell viability.

For the colony-forming efficiency assays, cells were labeled for 2 h at the indicated doses. The labeled cells were then trypsinized, washed to remove label, and replated in duplicate culture dishes at 1000 and 2000 cells/dish. Cells were fed with complete M199 medium every other day for 7 days, after which they were fixed and stained with 0.25% crystal violet in 2% formaldehyde/80% methanol. The colonies (which were defined as a minimum of 100 cells in a cluster) were counted manually for both labeled and unlabeled (control) samples and percent colony formation was corrected according to the plating efficiency (PE) of the control cells. Percent colony formation = 100 x number of colonies established/number of cells seeded x PE, where PE = number of colonies established by unlabeled cells/total number of cells seeded. PE for the experiment shown in Fig. 5 was ~36%.



View larger version (10K):
[in this window]
[in a new window]
 
Figure 5. Colony formation by cells labeled with different concentrations of 35S-Trans label. Cells were labeled for 2 h at different doses of 35S-Trans label, and colony formation was determined after 7 days as described in Materials and Methods. A) Percent colony formation (± SE) relative to unlabeled control as a function of the concentration of radiolabel present during the 2 h labeling period. Data shown for 35S-Trans label at 0.1, 1, 10, and 100 µCi/ml. B) Percent colony formation (± SE) expressed as a function of the amount of radiolabel uptake into cells. Duplicate dishes seeded at both 1000 and 2000 cells/dish were used to determine the percent colony formation. The amount of radiolabel uptake/cell was determined for each sample after the 2 h labeling period by scintillation counting of aliquots of the supernatant and pelleted cells after labeling. This value was divided by the total number of cells in the sample, which was determined by direct cell counting. The specific activity of the 35S-Trans label used in these studies was 1175 Ci/mmol [ICN].

Morphological analyses
Cell morphology after radiolabeling was examined by both bright-field and fluorescence microscopy using an Olympus IX70-inverted system microscope equipped with an IX-FLA inverted reflected light fluorescence observation attachment. Pictures were recorded with an Olympus PM-20 photomicrographic system using both 20x and 40x objectives on the microscope. Some samples were fixed and stained with PI as described above to better identify morphological changes in cell nuclei.

Apoptosis assay
Cells were washed with PBS and stained with annexin V-Oregon Green (Trevigen, Inc.) [250 µg/ml] for 15 min in the dark. The live cells were then examined with an inverted fluorescence microscope, and both phase contrast and fluorescence images were recorded photographically. To quantitate apoptosis, the number of Oregon Green-stained cells were counted and divided by the total number of cells in the area examined. To facilitate cell count and to preserve the cell-associated fluroescence for a longer period of time, the radiolabeled cells were fixed with cold methanol after staining live cells with annexin V-Oregon Green and also stained with PI to highlight the nuclei. The number of Oregon Green-stained cells in both radiolabeled and control samples were counted within a 10 x 10 grid on the fluorescence microscope and divided by the number of nuclei (or total cell number) in the same area.

Statistical analyses
All data are expressed as means ± SE. The Student’s t test was used to determine statistical significance of the difference between labeled samples vs. matched controls.


   RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
APPENDIX 1
APPENDIX 2
REFERENCES
 
Metabolic labeling with [35S]methionine inhibits cell progression into mitosis
Mitotic cells are often harvested from cell cultures treated with nocodazole, a microtubule-disrupting drug commonly used to induce mitotic arrest (14) . Figure 1 shows that metabolic labeling of rabbit smooth muscle cells with [35S]methionine at 100 µCi/ml prevents the normal accumulation of mitotic cells in the presence of nocodazole. Neither the commercial source of the label nor the composition of the carrier buffer was a factor in this inhibition, as shown in Fig. 1 . In separate studies, removal of the label after an overnight or a 2 h pulse labeling period also failed to reverse the inhibition (data not shown). The effect of a 30 min prelabeling amino acid depletion protocol was considered as a possible cause of mitotic inhibition despite ample mitotic cell accumulation in the similarly starved unlabeled control. This possibility was ruled out by the observations that decreasing the preincubation time with depleted medium to 5 min and labeling of cells in complete medium (without any starvation period) had no influence on the inhibitory effects of the radiolabel on mitotic induction. Furthermore, the effect of [35S]methionine was not cell type specific, as several different cell lines were similarly inhibited in terms of entry into mitosis (Fig. 2 ). Thus, we postulated that exposure to standard amounts of [35S]methionine induced a form of cell cycle arrest.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 1. Effect of [35S]methionine from different sources on accumulation of mitotic cells in the presence of nocodazole. The numbers of rounded (mitotic) cells were determined for control (open bars) and [35S]methionine-treated cells (filled bars). Different formulations of [35S]methionine were used: A) 35S-Trans label [ICN], B) Redi-vue [35S]methionine, and C) [35S]methionine in vivo cell label [the latter two from Amersham]. Controls were treated with the following carrier buffers in place of radiolabel: A) 50 mM L-lysine, pH 7.4 with 10 mM beta-mercaptoethanol; B) Redi-vue buffer, a proprietary solution that did not contain reducing agent; C) 50 mM pyridine3,4-dicarboxylic acid with 0.1% beta-mercaptoethanol. The appropriate carrier buffer was used in all of the control samples described in this report. The results show the mean number of mitotic cells (± SE) counted in 5 separate areas on the culture dish. This experiment is representative of more than 30 such experiments performed on these cells. *P<0.01 vs. control.

35S-methionine induces cell cycle arrest
This postulate was confirmed by cell cycle analyses using PI staining for DNA content and adapted for analysis of anchored cells using scanning laser cytometry (13) . As shown in Fig. 3A , unlabeled cells synchronized at the G1/S transition by a thymidine-mimosine double block procedure (12) are characterized by a single peak in the fluorescence profile of PI-stained cells, representing cells with 2n DNA content immediately after washout of mimosine. Figure 3B shows the appearance of the G2 peak 8 h after release from the mimosine block, with the G2 peak having a mean fluorescence value approximately twice that of the G1 peak, corresponding to cells with 4n DNA content. Figure 3C shows that 24 h after the mimosine washout, a large fraction of unlabeled control cells had returned to G1 and were proceeding once again into S phase. At the same time point, a sample that had been labeled for 2 h with [35S]methionine immediately after washout of mimosine and chased with cold complete medium for 22 h was still predominantly in the initial G2 phase (Fig. 3D ), having never rounded up. Since all cells in this experiment had been previously synchronized to the G1/S interface, these studies suggest that [35S]methionine incorporation into cells can induce cell cycle arrest, even though DNA replication is not inhibited by this protocol. This G2 arrest was independent of the presence of nocodazole in the culture medium since the radiolabeled sample had not been treated with nocodazole. Two earlier experiments (2 , 3) had associated radiolabeling with [35S]methionine with an increase in p53 levels, normally associated with G1 arrest. In light of our observations of a [35S]methionine-induced G2 arrest, several possibilities can be considered: 1) elevated p53 levels can also induce G2 arrest, as reported elsewhere (15 16 17 18) ; 2) a p53-independent mechanism is involved in radioisotope-induced cell cycle arrest, as has been suggested for other forms of irradiation (3 , 5) ; 3) the stage and/or mechanism of cell cycle arrest may be dependent on the cell cycle compartment in which the label is introduced or on the cell type involved. The resolution of these possibilities awaits further experimentation.

35S-metabolic labeling inhibits cell proliferation
To investigate the effect of metabolic labeling on cell proliferation, rabbit smooth muscle cells labeled for 2 h with [35S]methionine were washed thoroughly to remove label and cultured for additional periods of time. Figure 4 shows that whereas the unlabeled control cells increased in number over the course of 3 days, the labeled cells showed no increase and, in some experiments, decreased in number (data not shown). Colony-forming efficiency assays were conducted at different concentrations of 35S-Trans label to assess the effects of varying doses of radiolabel on long-term survival and proliferation of cells. The results (Fig. 5A ) not only show that cells labeled for 2 h at 100 µCi/ml failed to form colonies over a period of 7 days, but also that a 1000-fold reduction in the radioisotope concentration to 0.1 µCi/ml yields a 40% reduction in the number of colonies formed relative to unlabeled control cells. When expressed as a function of pCi uptake/cell (Fig. 5B ), it is clear that the inhibition of colony formation correlates directly with the amount of radioactivity incorporated. Furthermore, relatively few atoms of 35S [0.07 pCi/cell corresponds to ~36,000 molecules of radiolabel] can cause substantial inhibition of cell proliferation (~ 40%), suggesting that critical targets may be damaged by this low-energy beta emitter. It will be interesting to determine the exact nature of the target(s) as well as its relation to cell cycle progression and apoptosis. It is noteworthy that there were still some live cells in the dishes labeled at 100 µCi/ml, some of which appeared to have undergone a few rounds of replication. However, these cells were altered in morphology (see below), and the number of such cells in a cluster did not meet the criterion set for a ‘colony’. It remains to be seen whether the surviving cells in these small clusters are transiently growth-arrested, terminally differentiated, or altered with respect to the length of the cell cycle. The colony-forming efficiency assays thus indicate that even very low levels of radiolabeling (0.1–1 µCi/ml) can induce inhibition of cell proliferation and/or cell death.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 4. Effect of 35S-Trans label on cell proliferation. Cells were labeled for 2 h with 35S-label, washed, and then left in culture for the indicated number of days before counting viable cells in control (open bars) or radiolabeled (filled bars) samples. The results show the mean number of cells from duplicate cultures of each sample (± SE). *P<0.01 vs. control.

Radiolabeling dramatically alters cell morphology
Along with the inhibition of cell proliferation, we observed dramatic changes in cell morphology for the radiolabeled smooth muscle cells from predominantly spindle-shaped cells (Fig. 6A ) to enlarged, multinucleated, irregularly shaped cells (Figs. 6B, C ). Yeargin and Haas (3) also reported that radiolabeling of human foreskin fibroblasts induced the appearance of large, senescent-like cells that remained quiescent for 17 days. PI-staining confirmed the presence of multinucleated cells as well as cells with fragmented nuclei (Figs. 6E, F ). These morphological changes prompted us to examine the effects of [35S]methionine on apoptosis.



View larger version (52K):
[in this window]
[in a new window]
 
Figure 6. Effect of 35S-radiolabeling on cell and nuclear morphology. Cells were labeled for 2 h with [35S]methionine at 100 µCi/ml, washed, and left in culture for 2 days before examination by phase contrast (A–C) or fluorescence (D–F) microscopy. A) Rabbit smooth muscle cells, unlabeled control; B, C) radiolabeled cells. Some cultures were fixed and then stained with PI to visualize the cell nuclei more clearly. D) Unlabeled cells showing normal nuclei; E, F) labeled cells showing multiple or fragmented nuclei. Panels A–C, F are at 92x; panels D, E are at 259x.

Radiolabeling induces delayed apoptosis of cells
Labeled and unlabeled cells were examined for signs of apoptosis using a fluorescent conjugate of annexin V, a protein that strongly and specifically binds to phophatidylserine (PS), which flips from the inner to the outer monolayer of the plasma membrane as the cell undergoes apoptosis. The resulting exposure of PS on the cell surface as detected by annexin V binding is often taken as a marker for early stages of apoptosis and occurs well before DNA fragmentation or trypan blue staining is detectable (19) . Figure 7 shows that radiolabeled cells showed an enhancement of apoptosis in comparison to unlabeled control cells. The amount of apoptosis in radiolabeled cell cultures was comparable to or exceeded the amount of apoptosis induced by exposure of these cells to chromium, an environmental toxin previously shown to induce apoptosis (20) . The degree of apoptosis increased as a function of time after a 2 h exposure to radiolabel, suggesting that metabolic radiolabeling and incorporated [35S]methionine can induce delayed apoptosis. By contrast, trypan blue staining immediately after the 2 h labeling period did not show any significant decrease in cell viability (data not shown).



View larger version (14K):
[in this window]
[in a new window]
 
Figure 7. Radiolabeling induces apoptosis of cells. Cells were labeled for 2 h with [35S]methionine at 100 µCi/ml, then washed and left in culture for an additional 4 h (A), 24 h (B), or 48 h (C) before staining with annexin V-Oregon Green. As a positive control for apoptosis, cells were treated with 100 µM sodium chromate for 2 h before analysis with annexin V (D). The percent annexin-stained cells was determined as described in Materials and Methods. An average of 223 cells were counted per sample. The results show the mean percent of annexin-stained cells (± SE) over 3 separate areas. The filled bars represent labeled (A–C) or Cr-treated (D) cells while the open bars represent buffer-treated controls. *P<0.02 vs. control.

The results described collectively suggest that low level beta emitters, particularly [35S]methionine at the concentration typically used in metabolic labeling experiments, can cause cell cycle arrest, long-term inhibition of proliferation, and apoptosis of cells. These results may not be so surprising if one considers the amount of radioactive decay energy the cell is exposed to during labeling as well as after metabolic incorporation of the radiolabel. An estimate of the initial dose rate or energy emitted by 100 µCi 35S in a 1 ml volume (typical concentration of [35S]methionine in metabolic labeling experiments) is 1.8 x 105 MeV/s-g or ~10 rad/h (See Appendix 1 for calculations). For comparison, 10 R (~10 rad) of whole body radiation can cause an elevated number of chromosome aberrations (though no detectable injury) in peripheral blood cells, and an exposure of 20 R to the reproductive system can cause a doubling of spontaneous mutations (21) . After a cellular uptake of ~40% of the label (present initially at 100 µCi/ml), the amount of energy released per cell/h is 230 MeV per cell/h or 2.3 x 10-4 erg per cell/h (Appendix 2). Our colony-forming assays also show that even very low levels of radioisotope uptake (e.g.,. 0.07 pCi/cell) can cause significant inhibition of cell proliferation. Thus, these results and calculations suggest a substantial potential for DNA and/or cellular damage by ionizing beta radiation from incorporated 35S atoms, as evidenced by earlier radiotoxicity assays (5) . In view of this and earlier studies (2 , 3 , 5) , we suggest that caution should be exercised in using metabolic radiolabeling techniques (especially for experiments involving cycling cells) as well as in evaluating and interpreting the literature involving the application of these methods. Furthermore, efforts should be directed toward finding alternative methods for following the biosynthesis, modification, and degradation of proteins in vivo. One possible alternative might involve the use of stable isotopes to follow protein expression and modification (22) . Aside from the obvious impact on experimental design, these results would also suggest the reevaluation of acceptable exposure levels to low-energy beta-emitting radioisotopes in the workplace, clinic, and environment.


   APPENDIX 1
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
APPENDIX 1
APPENDIX 2
REFERENCES
 
Calculation of initial dose rate for cells exposed to 100 µCi 35S-methionine:
Cells: monolayer of cells in 35 mm culture dish in 1 ml medium

Estimated mass of region irradiated during first hour: ~1 g [1 ml medium + cells]

Concentration of label: 100 µCi of 35S-methionine/ml ~ 100 µCi/g

Average beta energy of 35S: 0.049 MeV/disintegration

1 millirad = 62,500 MeV/g

Energy emitted/s

= Concentration of label/gm x (disintegrations/s) x (energy/disintegration)

= 100 µCi/g x 3.7 x 104 dps x 0.049 MeV/disintegration

= 1.8 x 105 MeV/s-g

Initial dose rate

= [1.8 x 105 MeV/s-g]/62,500 MeV/g-mrad

= 2.92 mrad/s ~ 10,500 mrad/h = 10 rad/h (in culture dish)


   APPENDIX 2
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
APPENDIX 1
APPENDIX 2
REFERENCES
 
Calculation of energy released/h/cell:
Fraction of 35S-Met uptake per cell = 40% (experimentally determined):

Total added: 100 µCi [specific activity = 1175 Ci/mmol]

Number of cells: 106

Amount of 35S-Met taken up by cells:

40 µCi/1.175 x 109 µCi/mmol

= 34 x 10-9 mmol/106 cells

= 34 x 10-18 mol/cell x 6.02 x 1023 molecules/mol/cell

= 2 x 107 molecules/cell

Fractional disintegration in first hour = 1/2112, given 88 day half-life of 35S

Average beta energy = 0.049 MeV

Amount of energy released per cell/h:

0.5 x 2 x 107 35S atoms/cell x 1/2112 x 0.049 MeV/ disintegration = 230 MeV per cell/h or 2.3 x 10-4 erg per cell/h


   ACKNOWLEDGMENTS
 
We thank Drs. Julia Albright, Patricia Berg, Susan Ceryak, Allan Goldstein, Jatinder Singh, and Barry Wessels for helpful discussions and suggestions during the course of this work. We also thank Dr. Steven Patierno for the use of his fluorescence microscope and photomicrographic system. This work was supported in part by an intramural FREF grant.


   FOOTNOTES
 
Received for publication August 4, 1999. Accepted for publication October 10, 1999.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
APPENDIX 1
APPENDIX 2
REFERENCES
 

  1. Solary, E., Bertrand, R., Jenkins, J., Pommier, Y. (1992) Radiolabeling of DNA can induce its fragmentation in HL-60 human promyelocytic leukemic cells. Exp. Cell Res. 203,495-498[Medline]
  2. Dover, R., Jayaram, Y., Patel, K., Chinery, R. (1994) p53 expression in cultured cells following radioisotope labelling. J. Cell Sci. 107,1181-1184[Abstract]
  3. Yeargin, J., Haas, M. (1995) Elevated levels of wild-type p53 induced by radiolabeling of cells leads to apoptosis or sustained growth arrest. Curr. Biol. 5,423-431[Medline]
  4. Hofer, K. G., W. L. Hughes, W. L. (1971) Radiotoxicity of intranuclear tritium, 125iodine and 131iodine. Radiat. Res. 47,94-109[Medline]
  5. Kassis, A.I., Adelstein, S. J. (1980) Radiotoxicity of 75Se and 35S: Theory and application to a cellular model. Radiat. Res. 84,407-425[Medline]
  6. LeMotte, P. K., Adelstein, S. J., Little, J. B. (1982) Malignant transformation induced by incorporated radionuclides in BALB/3T3 mouse embryo fibroblasts. Proc. Natl. Acad. Sci. USA 79,7763-7767[Abstract/Free Full Text]
  7. Herzinger, T., Funk, J. O., Hillmer, K., Eick, D., Wolf, D. A., Kind, P. (1995) Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase. Oncogene 11,2151-2156[Medline]
  8. Poon, R. Y. C., Jiang, W., Toyoshima, H., Hunter, T. (1996) Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J. Biol. Chem. 271,13283-13291[Abstract/Free Full Text]
  9. Poon, R. Y. C., Chau, M. S., Yamashita, K., Hunter, T. (1997) The role of cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res 57,5168-5178[Abstract/Free Full Text]
  10. DiLeonardo, A., Linke, S. P., Clarkin, K., Wahl, G. M. (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8,2540-2551[Abstract/Free Full Text]
  11. S. P. Linke, S. P., Clarkin, K. C., Wahl, G. M. (1997) p53 mediates permanent arrest over multiple cell cycles in response to {gamma}-irradiation. Cancer Res 57,1171-1179[Abstract/Free Full Text]
  12. Spector, D. L., Goldman, R. D., Leinwand, L. A. (1997) Cell synchronization. Cells: A Laboratory Manual Vol. 1, Chap. 14,14.1-14.13 Cold Spring Harbor Laboratory Press New York.
  13. Xie, H., Hu, V. W. (1994) Evidence for M-phase-specific modification of a gap junction protein. Hu, V. W. eds. The Cell Cycle: Regulators, Targets, and Clinical Applications ,223-228 Plenum Press New York.
  14. Zieve, G. W., Turnbull, D., Mullins, J. M., McIntosh, J. R. (1980) Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Exp. Cell Res. 126,397-405[Medline]
  15. Agarwal, M. L., Agarwal, A., Taylor, W. R., Stark, G. R. (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92,8493-8497[Abstract/Free Full Text]
  16. Stewart, N., Hicks, G. G., Paraskevas, F., Mowat, M. (1995) Evidence for a second cell cycle block at G2/M by p53. Oncogene 10,109-115[Medline]
  17. Guillouf, C., Rosselli, F., Krishnaraju, K., Moustacchi, E., Hoffman, B., Liebermann, D. A. (1995) p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 10,2263-2270[Medline]
  18. Powell, S. N., DeFrank, J. S., Connell, P., Eogan, M., Preffer, F., Dombkowski, D., Tang, W., Friend, S. (1995) Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res 55,1643-1648[Abstract/Free Full Text]
  19. Martin, S. J., Teutelingsperger, C. P. M., McGahon, A. J., Rader, J. A., van Schie, R. C. A. A., LaFace, D. M., Green, D. R. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182,1545-1556[Abstract/Free Full Text]
  20. Singh, J., Carlisle, D. L., Pritchard, D. E., Patierno, S. R. (1998) Chromium-induced genotoxicity and apoptosis: Relationship to chromium carcinogenesis (Review). Oncol. Rep. 5,1307-1318[Medline]
  21. Shapiro, J. (1972) Radiation Protection: A Guide for Scientists and Physicians ,54-55 Harvard University Press Cambridge, Massachusetts.
  22. Oda, Y., Huang, K., Cross, F. R., Cowburn, D., Chait, B. T. (1999) Accurate quantitation of protein expression and site-specific phosphorylation. Proc. Natl. Acad. Sci. USA 96,6591-6596[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Virol.Home page
H. Yuan, M. Kamata, Y.-M. Xie, and I. S. Y. Chen
Increased Levels of Wee-1 Kinase in G2 Are Necessary for Vpr- and Gamma Irradiation-Induced G2 Arrest
J. Virol., August 1, 2004; 78(15): 8183 - 8190.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. F. MARKO, P. B. DIEFFENBACH, G. YAN, S. CERYAK, R. W. HOWELL, T. A. MCCAFFREY, and V. W. HU
Does metabolic radiolabeling stimulate the stress response? Gene expression profiling reveals differential cellular responses to internal beta vs. external gamma radiation
FASEB J, August 1, 2003; 17(11): 1470 - 1486.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Schulenberg, R. Aggeler, J. M. Beechem, R. A. Capaldi, and W. F. Patton
Analysis of Steady-state Protein Phosphorylation in Mitochondria Using a Novel Fluorescent Phosphosensor Dye
J. Biol. Chem., July 11, 2003; 278(29): 27251 - 27255.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
V. W. HU, D. S. HEIKKA, P. B. DIEFFENBACH, and L. HA
Metabolic radiolabeling: experimental tool or Trojan horse? 35S-Methionine induces DNA fragmentation and p53-dependent ROS production
FASEB J, July 1, 2001; 15(9): 1562 - 1568.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HU, V. W.
Right arrow Articles by HEIKKA, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HU, V. W.
Right arrow Articles by HEIKKA, D. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS